European Pharmaceutical Review
APRIL 11, 2025
The National Institute For Health and Care Excellence ( NICE )s has recommended a new combination treatment for advanced breast cancer patients. AstraZenecas Truqap (capivasertib) in combination with fulvestrant is indicated as a treatment option for around 1,100 UK adults with hormone receptor (HR)-positive HER2-negative breast cancer with certain genetic mutations.
STAT
APRIL 11, 2025
In an unexpected move, the U.S. Food and Drug Administration announced plans this week to reduce — and possibly replace — animal testing with other methods for developing certain medicines in a bid to lower R&D costs and, eventually, the prices for prescription drugs. The agency will encourage researchers to use computer modeling and artificial intelligence to predict how a drug will perform, as well as organs-on-a-chip, which are miniaturized devices that mimic organs and tiss
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
APRIL 11, 2025
In a highly regulated industry like pharmaceuticals, standing out online can feel like navigating a maze. Unlike retail or tech brands, pharma companies must balance compliance with creativity while communicating with multiple audiences. This is where SEO marketing strategies become essentialallowing brands to boost visibility, earn trust, and support both HCP and patient journeys without violating regulatory guidelines.
STAT
APRIL 11, 2025
WASHINGTON — An Alabama woman who lived with a pig kidney for a record 130 days had the organ removed after her body began rejecting it and is back on dialysis, doctors announced Friday — a disappointment in the ongoing quest for animal-to-human transplants. Towana Looney is recovering well from the April 4 removal surgery at NYU Langone Health and has returned home to Gadsden, Alabama.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The FDA Law Blog
APRIL 11, 2025
By Andrew J. Hull Last month, we blogged on the Department of Justices (DOJ) abrupt announcement that it had determined that removal restrictions protecting administrative law judges (ALJs) were unconstitutional and that DOJ would no longer defend those removal restrictions in court. We opined that while the impact of this statement was unclear, it was likely that this position would make it more difficult for litigants challenging the constitutionality of a proceeding presided by an ALJ.
STAT
APRIL 11, 2025
WASHINGTON — The Trump administration said Thursday that it will no longer help states fund non-medical services that often are aimed at improving housing and nutrition for people in the Medicaid program. The change is a departure from the Biden administration’s efforts to improve the health of Medicaid enrollees by paying for non-medical services.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
APRIL 11, 2025
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We expect to promenade with the official mascots, catch up on our growing reading list, and tidy up around the castle. We also hope to hold yet another listening party with Mrs.
Drug Topics
APRIL 11, 2025
Collaborative practice agreements enable pharmacists to leverage their expertise beyond traditional dispensing, but barriers continue to limit their implementation.
STAT
APRIL 11, 2025
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
PharmaVoice
APRIL 11, 2025
The tariff war has prompted new calls to reshore manufacturing. Several large pharmas have already made the leap.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
APRIL 11, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning, Jason Mast here filling in for Rose. Yesterday, STAT won a National Magazine Award for General Excellence. Judges for the award, one of the highest in American journalism, specifically wrote that STAT “uncovered the ongoing tragedy of sickle-cell patients pressured into sterilization; relentlessly documented the way UnitedHealth Group gobbled up hea
Drug Topics
APRIL 11, 2025
A conversation with Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, at the American Associated Pharmacies 2025 Annual Conference.
Pharmacy Times
APRIL 11, 2025
Meaningful reform was challenging in 2024, but this year could turn the tide.
Drug Topics
APRIL 11, 2025
The drug is also approved for adults with chronic inflammatory demyelinating polyneuropathy.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
APRIL 11, 2025
In business, growth for the sake of growth mirrors the ideology of the cancer cell.
Drug Topics
APRIL 11, 2025
A conversation with Scott Biggs and Greg Mitchell at the American Associated Pharmacies 2025 Annual Conference.
Pharmacy Times
APRIL 11, 2025
Rather than turning to vitamin K supplements, individuals should incorporate more vegetables into their diets.
Drug Topics
APRIL 11, 2025
David Blair, CEO of LucyRx, discusses the common challenges his clients face and how his companys innovative model can help them overcome financial hurdles.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
APRIL 11, 2025
In a letter sent to states, designated state health program requests with a healthcare-adjacent focus are unlikely to be approved, CMS announced. Here's what that means.
Drug Topics
APRIL 11, 2025
Dae Lee, PharmD, Esq, CPBS, discusses the legal and billing challenges hindering pharmacy practices and opportunities to overcome them.
Pharmaceutical Technology
APRIL 11, 2025
The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.
Drug Topics
APRIL 11, 2025
The new approval is the first nonopioid option for moderate to severe acute pain in adults.
Pharmaceutical Technology
APRIL 11, 2025
The twice daily tablet represents a significant step forward for patients with advanced breast cancer.
Pharmacy Times
APRIL 11, 2025
Patients with unresectable or metastatic hepatocellular carcinoma (HCC) receiving this regimen had favorable median overall survival (23.7 months) compared with standard of care (20.6 months).
pharmaphorum
APRIL 11, 2025
Novartis has announced a massive investment in manufacturing and R&D facilities in the US so it can make "100% of its key medicines" there
Pharmacy Times
APRIL 11, 2025
When used in combination with background statin therapy, AZD0780 resulted in major reductions in low-density lipoprotein cholesterol (LDL-C) and achievements of guideline-recommended LDL-C goals.
pharmaphorum
APRIL 11, 2025
The FDA has said it intends to reduce or replace animal testing of some medicines, including monoclonal antibodies, with other methods.
Fierce Healthcare
APRIL 11, 2025
The American Medical Association is seeking answers from Optum after reports from physicians indicated that the company pressuring them to repay loans issued following the cyberattack on Change Healthcare.
pharmaphorum
APRIL 11, 2025
Alzheon has been left sifting through data from a failed Alzheimer's trial for crumbs of evidence that its oral therapy may have some efficacy
Pharmacy Times
APRIL 11, 2025
Christine Barrett, PharmD, BCOP, shares insights, challenges, and advice for oncology pharmacists navigating neoadjuvant therapy.
pharmaphorum
APRIL 11, 2025
Robert F Kennedy Jr's controversial views on vaccines were on display this week during an interview that touched on delays to a COVID-19 shot review
Pharmacy Times
APRIL 11, 2025
Metrics should empower pharmacists rather than burden them.
Fierce Healthcare
APRIL 11, 2025
A new analysis of 18 payment models reaffirms criticisms of the Center for Medicare and Medicaid Innovation's cost savings success. Still, a subset of the models drove value in cost and quality and are strong targets for expansion or iteration, authors wrote.
Expert insights. Personalized for you.
Let's personalize your content